[1] McGill Univ, Montreal, PQ, Canada
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[4] Natl Canc Ctr, Singapore, Singapore
[5] Princess Alexandra Hosp, Brisbane, Qld, Australia
[6] Queensland Univ Technol, Brisbane, Qld, Australia
[7] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[8] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[9] Chinese Univ Hong Kong, Dept Clin Oncol, Key Lab South China, Hong Kong, Peoples R China
[10] Chungbuk Natl Univ Hosp, Cheongju, North Chungcheo, South Korea
[11] Shanghai Chest Hosp, Shanghai, Peoples R China
[12] Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China
[13] Peking Union Med Coll, Beijing, Peoples R China
[14] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China
[15] Asan Med Ctr, Seoul, South Korea
[16] BC Canc Agcy, Vancouver, BC, Canada
[17] Seoul Natl Univ Hosp, Seoul, South Korea
[18] Ctr Francois Baclesse, Oncol, Caen, France
[19] Karolinska Univ Hosp, Stockholm, Sweden
[20] Univ Hosp Essen, Univ Duisburg Essen, West German Canc Ctr, Essen, Germany
[21] Boehringer Ingelheim Ltd UK, Bracknell, Berks, England
[22] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[23] Hosp Univ Doce Octubre, Madrid, Spain
[24] CNIO, Madrid, Spain
[25] Sungkyunkwan Univ, Canc Med Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea
